Factors Associated With Mortality in Streptococcal Anginosus Bacteremia
NCT07343167 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-01-15
Summary
Streptococcal anginosus infections (S. constellatus, S. anginosus, and S. intermedius) are characterized by their severity, linked to high mortality and frequent infectious complications. Several studies in the literature highlight this severity, with mortality rates estimated at around 15%.
The aim of this research is to identify the factors associated with mortality in Streptococcal anginosus bacteremia.
Conditions
- Streptococcal Infections
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-08
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-08
Countries
- France
Study Locations
More Related Trials
-
Treatment of Enterococcus Faecalis Bacterem
NCT07299539 ·Status: RECRUITING
-
Early Antibiotic Therapy and Vaccination
NCT04109833 ·Status: UNKNOWN
-
Contamination of Bacillus Species Sepsis.
NCT03377530 ·Status: COMPLETED
-
Rapid Detection of Bacterial Resistance by MALDI-TOF MS and Antibiotic Savings
NCT02860247 ·Status: COMPLETED
-
Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection
NCT03419221 ·Status: COMPLETED ·Phase: NA
-
Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics
NCT07111793 ·Status: RECRUITING ·Phase: NA
-
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
NCT01792804 ·Status: COMPLETED ·Phase: PHASE3
-
Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis
NCT03140410 ·Status: UNKNOWN
-
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
NCT01191840 ·Status: COMPLETED ·Phase: PHASE2
-
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
NCT05361135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients with Enterobacterales Bacteremia
NCT06425367 ·Status: RECRUITING ·Phase: NA
-
Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar
NCT06218277 ·Status: COMPLETED ·Phase: NA
-
Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome
NCT05193058 ·Status: UNKNOWN
-
Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections
NCT02271243 ·Status: RECRUITING
-
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
NCT00175370 ·Status: COMPLETED ·Phase: NA
-
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
NCT00177957 ·Status: COMPLETED
-
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
NCT00691600 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections
NCT00990392 ·Status: WITHDRAWN ·Phase: NA
-
Neonatal Antimicrobial Resistance and Outcome
NCT05743816 ·Status: UNKNOWN
-
Multi-resistant and Spore-forming Bacteria in a Neonatal Intensive Care Unit
NCT06391463 ·Status: ENROLLING_BY_INVITATION
-
Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings
NCT07202377 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS
NCT06058819 ·Status: RECRUITING
-
Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
NCT05002413 ·Status: COMPLETED
-
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus
NCT02701595 ·Status: COMPLETED ·Phase: PHASE3